trending Market Intelligence /marketintelligence/en/news-insights/trending/-pP8Y7_EboqVU99ROTx6fA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

HealthCare Royalty Partners raises $1.83B for new flagship fund

StreetTalk – Episode 70: Banks' Liquidity Conundrum Could Fuel M&A Activity

Street Talk Episode 70 - Banks' Liquidity Conundrum Could Fuel M&A Activity

StreetTalk – Episode 69: Banks left with pockets full of cash and few places to go

Street Talk – Episode 69: Banks left with pockets full of cash and few places to go


HealthCare Royalty Partners raises $1.83B for new flagship fund

HealthCare Royalty Partners secured $1.83 billion at the close of its Healthcare Royalty Partners IV LP vehicle and affiliated funds.

The Stamford, Conn.-based private investment firm received capital from new and existing partners.

HealthCare Royalty will use the raised funds to buy royalties and revenue interests from commercial biopharmaceutical products and provide debt financing with mainly commercial stage assets as collateral. The firm typically invests between $20 million and $200 million.

Additionally, HealthCare Royalty promoted four individuals to managing director, including Carlos Almodóvar, head of investor relations; Shin Kang, head of research; Andrew Reardon, chief legal officer; and Spencer Schneider, chief compliance officer and intellectual property counsel.